VALEANT PHARMACEUTICALS INTERNATIONAL·4

Feb 13, 4:15 PM ET

Min Steve T. 4

4 · VALEANT PHARMACEUTICALS INTERNATIONAL · Filed Feb 13, 2009

Insider Transaction Report

Form 4
Period: 2008-06-30
Min Steve T.
EVP and General Counsel
Transactions
  • Award

    Common Stock

    2008-06-30+39,03939,039 total
Footnotes (1)
  • [F1]These restricted stock units are subject to specified performance criteria tied to total shareholder return as measured on certain specified dates.

Documents

2 files
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    EDGAR SUPPORTING DOCUMENT